Jeffrey Goldberger, MD
Clinical Cardiac Electrophysiology · Miami, FLNPI 1033147673
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,775 of the $33,104 with a category attached, or 65.8%. Medtronic accounts for 65.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $14,740 and has fallen 97.7% since, to $336 in 2025.
Across 37 payments — averaging $894.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$22K
- Biotronik Inc.$10K
- Boston Scientific$674
- Cardiva Medical, Inc.$273
- Biosense Webster, Inc.$134
- Abbott$131
- plus $103 from 3 others
Across 1 payment — averaging $7332.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$7K
What the payments were for
- Consulting fees$21,77566%
- Grants$10,00030%
- Food & beverage$1,3294%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 4 | $21,791 |
| Biotronik Inc. | 1 | $10,000 |
| Boston Scientific | 14 | $674 |
| Cardiva Medical, Inc. | 10 | $273 |
| Biosense Webster, Inc. | 1 | $134 |
| Abbott | 2 | $131 |
| Inari Medical, Inc. | 3 | $69 |
| Philips North America LLC | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HeartWare HVAD$4,690
- Carto 3$134
- Trifecta GT Tissue Heart Valve$113
- Sentinel$112
- AVVIGO Guidance System$112
How this compares
$33,104 in reported general payments places this provider in the 60th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 87 | $104,676 |
| MultaqDronedarone Hcl | 23 | $27,861 |
| XareltoRivaroxaban | 26 | $21,535 |
| EntrestoSacubitril/Valsartan | 13 | $8,116 |
| Metoprolol Succinate | 68 | $858 |
| Amiodarone Hcl | 21 | $564 |
| Flecainide Acetate | 12 | $335 |
| Rosuvastatin Calcium | 14 | $286 |
| Amlodipine Besylate | 16 | $112 |
| Atorvastatin Calcium | 18 | $56 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Miami
- Jose Osorio FilhoMiami$1.2M
- Ivan MendozaMiami$122K
- Litsa LambrakosMiami$102K
- Mario PascualMiami$94K
- Fernando MeraMiami$82K
- Ricardo HernandezMiami$60K
- Usman SiddiquiWinter Park$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.